Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Vochelle

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Seminars in Thrombosis and Hemostasis|January 1, 1991
Use of enoxaparin, a low molecular weight heparin, in elective hip surgeryA Planes, N Vochelle, J Bouthier, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
Dose-finding studies of reviparin in elective hip surgeryA Planès, N Vochelle, S Chevret, et al.
The Journal of Bone and Joint Surgery. British Volume|May 1, 1991
Prevention of deep vein thrombosis after total hip replacement. The effect of low-molecular-weight heparin with spinal and general anaesthesiaA Planès, N Vochelle, M Fagola, et al.
Acta Chirurgica Scandinavica. Supplementum|January 1, 1990
Once-daily dosing of enoxaparin (a low molecular weight heparin) in prevention of deep vein thrombosis after total hip replacementA Planès, N Vochelle, M Fagola, et al.
Revista Espanola De Anestesiologia Y Reanimacion|July 12, 2001
[Prophylactic antithrombotic therapy after orthopedic surgery with bemiparin, a second-generation low molecular weight heparin]A Planès, N Vochelle, M J González De Suso, et al.
Lancet (London, England)|July 27, 1996
Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placeboA Planes, N Vochelle, J Y Darmon, et al.
Thrombosis and Haemostasis|November 24, 1989
The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacementM N Levine, A Planes, J Hirsh, et al.
American Journal of Surgery|April 1, 1991
Efficacy and safety of a perioperative enoxaparin regimen in total hip replacement under various anesthesiasA Planès, N Vochelle, M Fagola, et al.
Haemostasis|January 1, 1986
Enoxaparine low molecular weight heparin: its use in the prevention of deep venous thrombosis following total hip replacementA Planes, N Vochelle, J Ferru, et al.
Drugs|January 1, 1996
Efficacy and safety of postdischarge administration of enoxaparin in the prevention of deep venous thrombosis after total hip replacement. A prospective randomised double-blind placebo-controlled trialA Planes, N Vochelle, J Y Darmon, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Seminars in Thrombosis and Hemostasis|January 1, 1991
Use of enoxaparin, a low molecular weight heparin, in elective hip surgeryA Planes, N Vochelle, J Bouthier, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
Dose-finding studies of reviparin in elective hip surgeryA Planès, N Vochelle, S Chevret, et al.
The Journal of Bone and Joint Surgery. British Volume|May 1, 1991
Prevention of deep vein thrombosis after total hip replacement. The effect of low-molecular-weight heparin with spinal and general anaesthesiaA Planès, N Vochelle, M Fagola, et al.
Acta Chirurgica Scandinavica. Supplementum|January 1, 1990
Once-daily dosing of enoxaparin (a low molecular weight heparin) in prevention of deep vein thrombosis after total hip replacementA Planès, N Vochelle, M Fagola, et al.
Revista Espanola De Anestesiologia Y Reanimacion|July 12, 2001
[Prophylactic antithrombotic therapy after orthopedic surgery with bemiparin, a second-generation low molecular weight heparin]A Planès, N Vochelle, M J González De Suso, et al.
Lancet (London, England)|July 27, 1996
Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placeboA Planes, N Vochelle, J Y Darmon, et al.
Thrombosis and Haemostasis|November 24, 1989
The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacementM N Levine, A Planes, J Hirsh, et al.
American Journal of Surgery|April 1, 1991
Efficacy and safety of a perioperative enoxaparin regimen in total hip replacement under various anesthesiasA Planès, N Vochelle, M Fagola, et al.
Haemostasis|January 1, 1986
Enoxaparine low molecular weight heparin: its use in the prevention of deep venous thrombosis following total hip replacementA Planes, N Vochelle, J Ferru, et al.
Drugs|January 1, 1996
Efficacy and safety of postdischarge administration of enoxaparin in the prevention of deep venous thrombosis after total hip replacement. A prospective randomised double-blind placebo-controlled trialA Planes, N Vochelle, J Y Darmon, et al.
Pageof 3